Trial intelligence / Profile preview

Indomethacin cataplasm for soft tissue injury pain

CTR20131899Phase 3Completed

Sponsor
Imperial Pharmaceutical
Start
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of indomethacin in soft tissue injury, lumbodynia (LBP), Dorsalgia, adhesive capsulitis (AC), tendinitis, sponsored by Imperial Pharmaceutical. Started Apr 2014; status: completed.

02

Drugs

indomethacin
03

Conditions

soft tissue injurylumbodynia (LBP)Dorsalgiaadhesive capsulitis (AC)tendinitis

Beyond the preview

Go deeper on CTR20131899.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131899.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call